retatrutide trial status The experimental GLP-1 drug 'reta' also improved blood sugar and heart health metrics. But side effects led more than 1 in 10 to drop out of trials early: https://bit.ly/4x6Aexb Retatrutide Results: 28.3% Weight Loss

Bhatt, and A

She has taken care of me for 6 years, and is the best

Across patient records, the cough followed a recognizable pattern: Onset: Often developed weeks to months after starting GLP-1 therapy Duration: Frequently lasted longer than eight weeks, meeting criteria for chronic cough Clinical impact: Led to ENT referrals, reflux evaluations, asthma workups, and empiric treatments Clinical course: In some patients, cough-related visits decreased after stopping or switching therapy, although formal rechallenge data were limited Why Might GLP-1 Drugs Affect the Airway

In most myocarditis cases, cardiac abnormalities usually resolve without clinically relevant residual damage 159